ERBB2 and neoplasm: Among cases previously defined as HER2-negative (i.e., HER2 IHC 0, 1 +, or 2+ with no HER2 amplification by FISH), 230 (44.9%) primary tumours were HER2-low and 201 (39.3%) were really HER2-negative (IHC 0).